ALVESCO 50 MCG
CICLESONIDE : 50 MCG · DIN 02285592 · TAKEDA CANADA INC
Health Canada status: CANCELLED PRE MARKET
What is ALVESCO?
ALVESCO 50 MCG contains CICLESONIDE : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02285592, held by TAKEDA CANADA INC, supplied as AEROSOL, METERED DOSE for INHALATION administration. Health Canada currently lists it as cancelled pre market, status dated 10-Feb-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ALVESCO used for?
Alvesco ® (ciclesonide) is indicated for prophylactic management of steroid-responsive bronchial asthma in adults, adolescents and children 6 years of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02285592 |
|---|---|
| Brand name | ALVESCO |
| Generic / active ingredient | CICLESONIDE : 50 MCG |
| Manufacturer | TAKEDA CANADA INC |
| Strength | 50 MCG |
| Dosage form | AEROSOL, METERED DOSE |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03BA08 CICLESONIDE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 10-Feb-2017 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code R03BA08 CICLESONIDE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALVESCO | 100 MCG | AEROSOL, METERED DOSE | COVIS PHARMA GMBH | MARKETED | DIN 02285606 |
| ALVESCO | 200 MCG | AEROSOL, METERED DOSE | COVIS PHARMA GMBH | MARKETED | DIN 02285614 |
Who else supplies CICLESONIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CICLESONIDE appears in 36 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.